[08-06-2021] Added suf, pref and pos embedding. Changed the LSTM units to 32

| TRAIN           | tp    | fp  | fn  | #pred | #exp  | P     | R     | F1    |
|-----------------|-------|-----|-----|-------|-------|-------|-------|-------|
|                 |       |     |     |       |       |       |       |       |
| brand           | 1124  | 16  | 34  | 1140  | 1158  | 98.6% | 97.1% | 97.8% |
| drug            | 6929  | 146 | 327 | 7075  | 7256  | 97.9% | 95.5% | 96.7% |
| drug_n          | 390   | 69  | 137 | 459   | 527   | 85.0% | 74.0% | 79.1% |
| group           | 2414  | 220 | 272 | 2634  | 2686  | 91.6% | 89.9% | 90.8% |
|                 |       |     |     |       |       |       |       |       |
| M.avg           | -     | -   | -   | -     | -     | 93.3% | 89.1% | 91.1% |
|                 |       |     |     |       |       |       |       |       |
| m.avg           | 10857 | 451 | 770 | 11308 | 11627 | 96.0% | 93.4% | 94.7% |
| m.avg(no class) | 10913 | 395 | 714 | 11308 | 11627 | 96.5% | 93.9% | 95.2% |

| DEVEL           | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 122  | 28  | 238 | 150   | 360  | 81.3% | 33.9% | 47.8% |
| drug            | 1593 | 149 | 320 | 1742  | 1913 | 91.4% | 83.3% | 87.2% |
| drug_n          | 9    | 7   | 36  | 16    | 45   | 56.2% | 20.0% | 29.5% |
| group           | 498  | 156 | 183 | 654   | 681  | 76.1% | 73.1% | 74.6% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 76.3% | 52.6% | 59.8% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2222 | 340 | 777 | 2562  | 2999 | 86.7% | 74.1% | 79.9% |
| m.avg(no class) | 2289 | 273 | 710 | 2562  | 2999 | 89.3% | 76.3% | 82.3% |


| TEST            | tp   | fp  | fn  | #pred | #exp | P     | R     | F1    |
|-----------------|------|-----|-----|-------|------|-------|-------|-------|
|                 |      |     |     |       |      |       |       |       |
| brand           | 97   | 23  | 191 | 120   | 288  | 80.8% | 33.7% | 47.5% |
| drug            | 1733 | 158 | 387 | 1891  | 2120 | 91.6% | 81.7% | 86.4% |
| drug_n          | 3    | 13  | 69  | 16    | 72   | 18.8% | 4.2%  | 6.8%  |
| group           | 521  | 183 | 178 | 704   | 699  | 74.0% | 74.5% | 74.3% |
|                 |      |     |     |       |      |       |       |       |
| M.avg           | -    | -   | -   | -     | -    | 66.3% | 48.5% | 53.8% |
|                 |      |     |     |       |      |       |       |       |
| m.avg           | 2354 | 377 | 825 | 2731  | 3179 | 86.2% | 74.0% | 79.7% |
| m.avg(no class) | 2451 | 280 | 728 | 2731  | 3179 | 89.7% | 77.1% | 82.9% |

[08-06-2021] Adding another LSTM after the BiLSTm do not improve the results. Then, we reject this iteration

[08-06-2021] When running with the first experimentation. We use a Input + Embedding + BiLSTM + TimeDistributed for 20 epochs

|      TRAIN      	|   tp  	|  fp 	|  fn  	| #pred 	|  #exp 	|   P   	|   R   	|   F1  	|
|:---------------:	|:-----:	|:---:	|:----:	|:-----:	|:-----:	|:-----:	|:-----:	|:-----:	|
|        -        	|   -   	|  -  	|   -  	|   -   	|   -   	|   -   	|   -   	|   -   	|
|      brand      	|  1141 	|  14 	|  17  	|  1155 	|  1158 	| 98.8% 	| 98.5% 	| 98.7% 	|
|       drug      	|  6991 	|  77 	|  265 	|  7068 	|  7256 	| 98.9% 	| 96.3% 	| 97.6% 	|
|      drug_n     	|  418  	|  73 	|  109 	|  491  	|  527  	| 85.1% 	| 79.3% 	| 82.1% 	|
|      group      	|  2527 	| 115 	|  159 	|  2642 	|  2686 	| 95.6% 	| 94.1% 	| 94.9% 	|
|        -        	|  428  	| 190 	|  422 	|  618  	|  850  	| 69.3% 	| 50.4% 	| 58.3% 	|
|      M.avg      	|   -   	|  -  	|   -  	|   -   	|   -   	| 94.6% 	| 92.1% 	| 93.3% 	|
|        -        	|  1949 	| 247 	| 1050 	|  2196 	|  2999 	| 88.8% 	| 65.0% 	| 75.0% 	|
|      m.avg      	| 11077 	| 279 	|  550 	| 11356 	| 11627 	| 97.5% 	| 95.3% 	| 96.4% 	|
| m.avg(no class) 	| 11101 	| 255 	|  526 	| 11356 	| 11627 	| 97.8% 	| 95.5% 	| 96.6% 	|

|      DEVEL      	|  tp  	|  fp 	|  fn  	| #pred 	| #exp 	|    P   	|   R   	|   F1  	|
|:---------------:	|:----:	|:---:	|:----:	|:-----:	|:----:	|:------:	|:-----:	|:-----:	|
|        -        	|   -  	|  -  	|   -  	|   -   	|   -  	|    -   	|   -   	|   -   	|
|      brand      	|  45  	|  0  	|  315 	|   45  	|  360 	| 100.0% 	| 12.5% 	| 22.2% 	|
|       drug      	| 1367 	| 138 	|  546 	|  1505 	| 1913 	|  90.8% 	| 71.5% 	| 80.0% 	|
|      drug_n     	|   6  	|  10 	|  39  	|   16  	|  45  	|  37.5% 	| 13.3% 	| 19.7% 	|
|      group      	|  491 	| 139 	|  190 	|  630  	|  681 	|  77.9% 	| 72.1% 	| 74.9% 	|
|        -        	|   -  	|  -  	|   -  	|   -   	|   -  	|    -   	|   -   	|   -   	|
|      M.avg      	|   -  	|  -  	|   -  	|   -   	|   -  	|  76.6% 	| 42.3% 	| 49.2% 	|
|        -        	|  428 	| 190 	|  422 	|  618  	|  850 	|  69.3% 	| 50.4% 	| 58.3% 	|
|      m.avg      	| 1909 	| 287 	| 1090 	|  2196 	| 2999 	|  86.9% 	| 63.7% 	| 73.5% 	|
| m.avg(no class) 	| 1949 	| 247 	| 1050 	|  2196 	| 2999 	|  88.8% 	| 65.0% 	| 75.0% 	|

|       TEST      	|  tp  	|  fp 	|  fn  	| #pred 	| #exp 	|   P   	|   R   	|   F1  	|
|:---------------:	|:----:	|:---:	|:----:	|:-----:	|:----:	|:-----:	|:-----:	|:-----:	|
|        -        	|   -  	|  -  	|   -  	|   -   	|   -  	|   -   	|   -   	|   -   	|
|      brand      	|  80  	|  5  	|  208 	|   85  	|  288 	| 94.1% 	| 27.8% 	| 42.9% 	|
|       drug      	| 1547 	| 117 	|  573 	|  1664 	| 2120 	| 93.0% 	| 73.0% 	| 81.8% 	|
|      drug_n     	|   0  	|  12 	|  72  	|   12  	|  72  	|  0.0% 	|  0.0% 	|  0.0% 	|
|      group      	|  542 	| 188 	|  157 	|  730  	|  699 	| 74.2% 	| 77.5% 	| 75.9% 	|
|        -        	|   -  	|  -  	|   -  	|   -   	|   -  	|   -   	|   -   	|   -   	|
|      M.avg      	|   -  	|  -  	|   -  	|   -   	|   -  	| 65.3% 	| 44.6% 	| 50.1% 	|
|        -        	|  428 	| 190 	|  422 	|  618  	|  850 	| 69.3% 	| 50.4% 	| 58.3% 	|
|      m.avg      	| 2169 	| 322 	| 1010 	|  2491 	| 3179 	| 87.1% 	| 68.2% 	| 76.5% 	|
| m.avg(no class) 	| 2235 	| 256 	|  944 	|  2491 	| 3179 	| 89.7% 	| 70.3% 	| 78.8% 	|


(created using: https://www.tablesgenerator.com/markdown_tables)
